PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportschronic obstructive pulmonary disease
MeSH D029424 - chronic obstructive pulmonary disease
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D002908:Chronic disease
0 Companies
0 Drugs
Success rate
D008173:Obstructive lung diseases
53 Companies
9 Drugs
$
Success rate
D029424: 
Chronic obstructive pulmonary disease
18 Companies
14 Drugs
$
Success rate
D000080445:Asthma-chronic obstructive pulmonary disease overlap syndrome
0 Companies
0 Drugs
Success rate
D011656:Pulmonary emphysema
99 Companies
21 Drugs
$
Success rate
D029481:Chronic bronchitis
50 Companies
16 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaSalmeterol, Fluticasone Aerivio Spiromax  2016-08-18   
Salmeterol xinafoate, Fluticasone Airexar Spiromax  2016-08-18   
Budesonide, Formoterol BiResp Spiromax  2014-04-28   
Budesonide, Formoterol Budesonide/Formoterol Teva  2014-11-19   
Budesonide, Formoterol DuoResp Spiromax  2014-04-28   
Budesonide, Formoterol Vylaer Spiromax  2014-11-19   
Budesonide, Formoterol Budesonide/Formoterol Teva Pharma B.V  2020-04-03   
MylanRoflumilast Roflumilast  2018-07-13   
Revefenacin Yupelri 2025-03-10 2018-11-09   
GSKUmeclidinium, Vilanterol Anoro Ellipta (previously Anoro)  2014-05-08   
Umeclidinium, Fluticasone furoate, Vilanterol Elebrato Ellipta  2017-11-15   
Umeclidinium Incruse Ellipta (previously Incruse)  2014-04-28   
Umeclidinium, Vilanterol Laventair Ellipta (previously Laventair)  2014-05-08   
Fluticasone furoate, Vilanterol Relvar Ellipta  2013-11-13   
Umeclidinium Rolufta Ellipta (previously Rolufta)  2017-03-20   
Umeclidinium, Fluticasone furoate, Vilanterol Temybric Ellipta  2019-06-12   
Umeclidinium, Fluticasone furoate, Vilanterol Trelegy Ellipta  2017-11-15   
Covis PharmaAclidinium, Formoterol Duaklir 2022-08-07 2019-03-29   
Aclidinium, Formoterol Duaklir Genuair  2014-11-19   
Aclidinium Eklira Genuair  2012-07-20   
Aclidinium Tudorza 2022-08-07 2012-07-23   
Aclidinium Bretaris Genuair  2012-07-20   
Aclidinium, Formoterol Brimica Genuair  2014-11-19   
AstraZenecaGlycopyrronium, Formoterol Bevespi Aerosphere  2018-12-18   
Roflumilast Daliresp 2023-02-19 2011-02-28 $189 M Q1/21-Q2/23 
Roflumilast Daxas  2010-07-05   
Roflumilast Libertek  2011-02-28   
Budesonide, Glycopyrronium, Formoterol Riltrava Aerosphere  2022-01-06   
Budesonide, Glycopyrronium, Formoterol Trixeo Aerosphere  2020-12-09   
NovartisIndacaterol Hirobriz Breezhaler  2009-11-30   
Indacaterol Onbrez Breezhaler  2009-11-29   
Indacaterol Oslif Breezhaler  2009-11-29   
Glycopyrronium Seebri Breezhaler  2012-09-28   
Glycopyrronium Tovanor Breezhaler  2012-09-28   
Indacaterol, Glycopyrronium Ultibro Breezhaler  2013-09-19   
Indacaterol, Glycopyrronium Ulunar Breezhaler  2014-04-23   
Indacaterol, Glycopyrronium Xoterna Breezhaler  2013-09-18   
Zydus TherapeuticsRoflumilast Roflumilast  2022-02-10   
Breckenridge PharmaceuticalRoflumilast Roflumilast  2018-10-03   
HeteroRoflumilast Roflumilast  2018-11-23   
Prinston PharmaceuticalRoflumilast Roflumilast  2022-05-10   
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
74%
67/91
Phase 2
62%
63/101
Phase 3
61%
71/116
Approved: 17Overall Success rate: 28%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Budesonide,
Fluticasone furoate,
Formoterol,
Formoterol fumarate dihydrate,
Salmeterol,
Fluticasone propionate,
Salmeterol xinafoate,
Fluticasone,
Procaterol,
Levosalbutamol,
Tv46017,
Tv48108
Mylan
Revefenacin,
Sodium chloride
GSK
Umeclidinium,
Umeclidinium bromide,
Fluticasone furoate,
Vilanterol,
Vilanterol acetate,
Losmapimod,
Hyaluronate sodium,
Antithrombin iii,
Clavulanate,
Fibrinogen,
Vitamin e,
Etrolizumab,
Cilomilast,
Alfacalcidol,
Sodium chloride,
BATEFENTEROL,
DANIRIXIN,
DAROTROPIUM BROMIDE,
DILMAPIMOD,
ELUBRIXIN,
MILVETEROL,
NEMIRALISIB,
Microcrystalline cellulose,
Levosalbutamol,
Gsk159802,
Gsk2256294,
Gsk610677,
Gsk256066
AstraZeneca
Roflumilast,
Budesonide,
Glycopyrronium,
Glycopyrronium bromide,
Formoterol,
Formoterol fumarate dihydrate,
Salicylic acid,
Benzocaine,
Vitamin e,
Tozorakimab,
Etrolizumab,
Sodium chloride,
ABEDITEROL,
ALVELESTAT,
NAVAFENTEROL,
VELSECORAT,
Levosalbutamol,
Azd2423,
Azd1981,
Azd8683,
Azd9164,
Azd5069,
Azd1236,
Bretzri,
Azd7624
Novartis
Indacaterol,
Glycopyrronium,
Glycopyrronium bromide,
Benzocaine,
Antithrombin iii,
Vitamin e,
Fevipiprant,
Bimagrumab,
Etrolizumab,
ACUMAPIMOD,
Levosalbutamol,
Qat370,
Qbm076,
Qak423a,
Bct197,
Csj117,
Qmf149
Chiesi Farmaceutici
Glycopyrronium,
Glycopyrronium bromide,
Beclometasone,
Formoterol,
Formoterol fumarate dihydrate,
Vitamin e,
Alfacalcidol,
Terfenadine,
Chf-6001,
Tranimilast,
Chf6523
1
2
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use